Abstract:Abstract Background The trisaccharide 2 ′ -fucosyllactose (2 ′ -FL) is one of the most abundant oligosaccharides found in human milk. Due to its prebiotic and anti-infective properties, 2 ′ -FL is discussed as nutritional additive for infant formula. Besides chemical synthesis and extraction from human milk, 2 ′ -FL can be produced enzymatically in vitro and in vivo . The most promising approach for a large-scale formation of 2 ′ -FL is the whole cell biosynthesis in Escherichia coli by intracellular synthesis of GDP-L-fucose and subsequent fucosylation of lactose with an appropriate α1,2-fucosyltransferase. Even though whole cell approaches have been demonstrated for the synthesis of 2 ′ -FL, further improvements of the engineered E. coli host are required to increase product yields. Furthermore, an antibiotic-free method of whole cell synthesis of 2 ′ -FL is desirable to simplify product purification and to avoid traces of antibiotics in a product with nutritional purpose. Results Here we report the construction of the first selection marker-free E. coli strain that produces 2 ′ -FL from lactose and glycerol. To construct this strain, recombinant genes of the de novo synthesis pathway for GDP-L-fucose as well as the gene for the H. pylori fucosyltransferase futC were integrated into the chromosome of E. coli JM109 by using the λ-Red recombineering technique. Strains carrying additional copies of the futC gene and/or the gene fkp (from Bacteroides fragilis ) for an additional salvage pathway for GDP-L-fucose production were used and shown to further improve production of 2 ′ -FL in shake flask experiments. An increase of the intracellular GDP-L-fucose concentration by expression of fkp gene as well as an additional copy of the futC gene lead to an enhanced formation of 2 ′ -FL. Using an improved production strain, feasibility of large scale 2 ′ -FL production was demonstrated in an antibiotic-free fed-batch fermentation (13 l) with a final 2 ′ -FL concentration of 20.28 ± 0.83 g l -1 and a space-time-yield of 0.57 g l -1 h -1 . Conclusions By chromosomal integration of recombinant genes, altering the copy number of these genes and analysis of 2 ′ -FL and intracellular GDP-L-fucose levels, we were able to construct and improve the first selection marker-free E. coli strain which is capable to produce 2 ′ -FL without the use of expression plasmids. Analysis of intracellular GDP-L-fucose levels identified the de novo synthesis pathway of GDP-L-fucose as one bottleneck in 2 ′ -FL production. In antibiotic-free fed-batch fermentation with an improved strain, scale-up of 2 ′ -FL could be demonstrated.

Production of GDP-l-fucose, l-fucose donor for fucosyloligosaccharide synthesis, in recombinant Escherichia coli

Enhanced production of GDP-l-fucose by overexpression of NADPH regenerator in recombinant Escherichia coli

Enhancing GDP-fucose Production in Recombinant Escherichia Coli by Metabolic Pathway Engineering.

Cell-free enzymatic synthesis of GDP-l-fucose from mannose

Modulation of guanosine nucleotides biosynthetic pathways enhanced GDP-l-fucose production in recombinant Escherichia coli

Metabolic engineering of Corynebacterium glutamicum to produce GDP-l-fucose from glucose and mannose

L-Fucose production by engineered Escherichia coli

Engineering Escherichia coli for Highly Efficient Biosynthesis of Lacto- N-difucohexaose II through De Novo GDP-l-fucose Pathway

Combinatorial metabolic engineering of industrial Gluconobacter oxydans DSM2343 for boosting 5-keto-D-gluconic acid accumulation

Efficient Biosynthesis of Difucosyllactose via De Novo GDP-l-Fucose Pathway in Metabolically Engineered Escherichia coli

Simultaneous production of 2′‐fucosyllactose and difucosyllactose by engineered Escherichia coli with high secretion efficiency

Engineering Escherichia coli MG1655 for Highly Efficient Biosynthesis of 2'-Fucosyllactose by De Novo GDP-Fucose Pathway

High-Level De Novo Biosynthesis of 2′-Fucosyllactose by Metabolically Engineered Escherichia coli

Functional expression of a human GDP-l-fucose transporter in Escherichia coli

De Novo Biosynthesis of Difucosyllactose by Artificial Pathway Construction and α1,3/4-Fucosyltransferase Rational Design in Escherichia coli

EFFICIENT PRODUCTION OF URIDINE 5′-DIPHOSPHO-N-ACETYLGLUCOSAMINE BY THE COMBINATION OF THREE RECOMBINANT ENZYMES AND YEAST CELLS

De novo biosynthesis of 2'-fucosyllactose in a metabolically engineered Escherichia coli using a novel ɑ1,2-fucosyltransferase from Azospirillum lipoferum

Engineering Escherichia coli for high-level production of lacto-N-fucopentaose I by stepwise de novo pathway construction

High-Yield Synthesis of 2'-Fucosyllactose from Glycerol and Glucose in Engineered Escherichia coli.

Enhanced Production of L-Tryptophan with Glucose Feeding and Surfactant Addition and Related Metabolic Flux Redistribution in the Recombinant Escherichia Coli

Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2′-fucosyllactose